NHD Global
Reproductive & Hormone · Source-reviewed dossier
Source-Reviewed Research Dossier
Gonadorelin is synthetic GnRH, the hypothalamic decapeptide that controls pituitary luteinizing-hormone and follicle-stimulating-hormone release. Physiological and medical effects depend strongly on pulsatile versus continuous exposure and cannot be reduced to a generic hormone claim.
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; the current product specification and lot COA control.
Product identity
Literature reference parameters
Identity safeguard Reference identifiers above describe the literature compound record. The supplied form, formula, molecular weight, purity and storage conditions must be verified against the product-specific specification and lot COA.
A target-to-pathway view grounded in the linked research records.
Reported research findings
Reported outcomes are paired with their experimental model and evidence boundary.
A current physiology review describes the native human GnRH-I sequence and its control of downstream gonadotropins.
Physiology does not establish efficacy of an unapproved supplied material.
Read the primary studyA review details GnRH-receptor signaling, desensitization and reproductive applications.
Analogue pharmacology should not be assigned to native gonadorelin without qualification.
Read the primary studyCatalog options
Pack-level catalog data; lot-level controls remain document-specific.
Single-component peptide · 2 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Request by lot: CoA, HPLC purity and MS identity
Single-component peptide · 5 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Request by lot: CoA, HPLC purity and MS identity
Single-component peptide · 10 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Request by lot: CoA, HPLC purity and MS identity
Document availability is stated honestly and can vary by catalog variant or lot.
Analytical interpretation
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Published studies and regulatory records, not customer testimonials or usage guidance.
Physiology does not establish efficacy of an unapproved supplied material.
View primary recordAnalogue pharmacology should not be assigned to native gonadorelin without qualification.
View primary recordThird-party publications selected for direct relevance.
StatPearls review. PMID 32644418.
Review. 2023. PMID 37958948.
Concise answers for researchers comparing identity, evidence and catalog variants.
Gonadorelin is synthetic GnRH, the hypothalamic decapeptide that controls pituitary luteinizing-hormone and follicle-stimulating-hormone release. Physiological and medical effects depend strongly on pulsatile versus continuous exposure and cannot be reduced to a generic hormone claim.
Human physiology and clinical literature are substantial, but formulation, dosing pattern and indication determine interpretation.
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.
Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.
Knowledge center
Owned educational content connected to this family.
Gonadorelin is synthetic GnRH. Its evidence cannot be summarized without exposure pattern: pulsatile signaling can support gonadotropin release, while sustained stimulation can produce receptor…
Updated September 8, 2026
Gonadorelin is the native-sequence GnRH decapeptide with N-terminal pyroglutamate and C-terminal glycinamide. Both terminal modifications are identity-defining.
Updated September 8, 2026Knowledge tools
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Selected: GND2 · 2 mg × 10 vials
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.
